Research programme: topical therapeutics - Biostar PharmaceuticalsAlternative Names: Viacom; Viacom Pine II Cream
Latest Information Update: 16 Jul 2016
At a glance
- Originator Fourth Military Medical University
- Developer BioStar Pharmaceuticals; Fourth Military Medical University
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Skin disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Skin-disorders in China (Topical, Cream)
- 13 Jun 2012 Preclinical trials in Skin disorders in China (Topical)